Home | | Pharmacology | Insulin Secretagogues: Sulfonylureas

Chapter: Basic & Clinical Pharmacology : Pancreatic Hormones & Antidiabetic Drugs

Insulin Secretagogues: Sulfonylureas

The major action of sulfonylureas is to increase insulin release from the pancreas.

INSULIN SECRETAGOGUES: SULFONYLUREAS

Mechanism of Action

The major action of sulfonylureas is to increase insulin release from the pancreas (Table 41–5). Two additional mechanisms of action have been proposed—a reduction of serum glucagon levels and closure of potassium channels in extrapancreatic tissue (which are of unknown but probably minimal significance).


A. Insulin Release from Pancreatic Beta Cells

Sulfonylureas bind to a 140-kDa high-affinity sulfonylurea recep-tor (Figure 41–2) that is associated with a beta-cell inward rectifier ATP-sensitive potassium channel. Binding of a sulfonylurea inhibits the efflux of potassium ions through the channel and results in depolarization. Depolarization opens a voltage-gated calcium channel and results in calcium influx and the release of preformed insulin.



B. Reduction of Serum Glucagon Concentrations

Long-term administration of sulfonylureas to type 2 diabetics reduces serum glucagon levels, which may contribute to the hypo-glycemic effect of the drugs. The mechanism for this suppressive effect of sulfonylureas on glucagon levels is unclear but appears to involve indirect inhibition due to enhanced release of both insulin and somatostatin, which inhibit alpha-cell secretion.

Efficacy & Safety of the Sulfonylureas

In 1970, the University Group Diabetes Program (UGDP) in the USA reported that the number of deaths due to cardiovascular disease in diabetic patients treated with tolbutamide was excessive compared with either insulin-treated patients or those receiving placebos. Owing to design flaws, this study and its conclusionswere not generally accepted. In the United Kingdom, the UKPDS did not find an untoward cardiovascular effect of sulfonylurea usage in their large, long-term study.


The sulfonylureas continue to be widely prescribed, and six are available in the USA (Table 41–6). They are conventionally divided into first-generation and second-generation agents, which differ primarily in their potency and adverse effects. The first-generation sulfonylureas are increasingly difficult to procure, and as the second-generation agents become generic and less expen-sive, the older compounds probably will be discontinued.


Study Material, Lecturing Notes, Assignment, Reference, Wiki description explanation, brief detail
Basic & Clinical Pharmacology : Pancreatic Hormones & Antidiabetic Drugs : Insulin Secretagogues: Sulfonylureas |


Privacy Policy, Terms and Conditions, DMCA Policy and Compliant

Copyright © 2018-2023 BrainKart.com; All Rights Reserved. Developed by Therithal info, Chennai.